IP Library Granted Patent US 7,595,377
Granted Patent B2
US 7,595,377 · App. 11/413,360 · Granted Sep 29, 2009

Substantially non-immunogenic injectable collagen

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,595,377
App. No.
11/413,360
Granted
Sep 29, 2009
Kind
B2
Abstract

The invention provides an article of manufacture comprising a substantially non-immunogenic injectable collagen for implantation into humans. The invention further provides methods for preparing injectable collagen material by removing collagen-containing material from a non-human animal; washing in saline and alcohol; subjecting material to cellular disruption treatment; and digesting the material with a proteoglycan-depleting factor and/or glycosidase and optionally following with a capping treatment. The invention also provides an article of manufacture produced by the method. The injectable collagen material of the invention are substantially non-immunogenic and have substantially the same mechanical properties as a corresponding native soft tissue.

Claims (6)

1. A xenogeneic, substantially non-immunogenic collagen-containing material for injection into a human, the collagen-containing material having extracellular components and dead chondrocyte cells with retained native surface glycoproteins substantially lacking immunogenic terminal alpha-1,3-Galactose oligosaccharide structures.

2. The collagen-containing material according to claim 1 in a form of liquid, colloid, semi-solid suspended particulate, gel or paste and combinations thereof.

3. The collagen-containing material of according to claim 2 wherein the collagen-containing material includes extracellular components and substantially only dead cells, the extracellular components and dead cells having substantially no surface alpha-galactosyl moieties and having capping molecules linked to at least a portion of surface carbohydrate moieties.

4. The collagen-containing material according to claim 2 wherein said collagen-containing material is sterilized pursuant to e-beam ionization irradiation.

5. The collagen-containing material according to claim 4 , wherein said sterilization is with a radiation dose approximately equal to 17.8 kGy.

6. The collagen-containing material according to claim 1 irradiated with gamma radiation in the amount of 0.2 MegaRad to about 3 MegaRad.

Assignments (2)
CHANGE OF NAME Recorded Jun 25, 2010
From: CROSSCART, INC.
To: APERION BIOLOGICS, INC.
Reel/Frame 024588/0851 →
CHANGE OF NAME Recorded Jan 12, 2010
From: CROSSCART, INC.
To: APERION BIOLOGICS, INC.
Reel/Frame 023758/0636 →